BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1512051)

  • 1. The role of the mucosal immune system in inflammatory bowel disease.
    Schreiber S; Raedler A; Stenson WF; MacDermott RP
    Gastroenterol Clin North Am; 1992 Jun; 21(2):451-502. PubMed ID: 1512051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the mucosal immune system in inflammatory bowel disease.
    MacDermott RP
    J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.
    Powrie F; Leach MW
    Ther Immunol; 1995 Apr; 2(2):115-23. PubMed ID: 8729882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in inflammatory bowel disease.
    Kmieć Z
    Arch Immunol Ther Exp (Warsz); 1998; 46(3):143-55. PubMed ID: 9704146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling for inflammation and repair in inflammatory bowel disease.
    Neuman MG
    Rom J Gastroenterol; 2004 Dec; 13(4):309-16. PubMed ID: 15624029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal T cells as a target for treatment of IBD.
    Watanabe M; Yamazaki M; Kanai T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():48-50. PubMed ID: 12698871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune dysfunction in inflammatory bowel disease.
    Neuman MG
    Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications.
    Amati L; Caradonna L; Jirillo E; Caccavo D
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):313-25. PubMed ID: 10425578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune response in inflammatory bowel disease.
    Brown SJ; Mayer L
    Am J Gastroenterol; 2007 Sep; 102(9):2058-69. PubMed ID: 17561966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiologic rationale for biological therapies in inflammatory bowel disease.
    Gordon JN; Di Sabatino A; Macdonald TT
    Curr Opin Gastroenterol; 2005 Jul; 21(4):431-7. PubMed ID: 15930983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
    Sartor RB
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraintestinal considerations in inflammatory bowel disease.
    Levine JB; Lukawski-Trubish D
    Gastroenterol Clin North Am; 1995 Sep; 24(3):633-46. PubMed ID: 8809240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunology of inflammatory diseases of the digestive tract].
    Barbier P
    Acta Chir Belg; 1989; 89(2):91-5. PubMed ID: 2667276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
    Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
    Caruso R; Fina D; Peluso I; Stolfi C; Fantini MC; Gioia V; Caprioli F; Del Vecchio Blanco G; Paoluzi OA; Macdonald TT; Pallone F; Monteleone G
    Gastroenterology; 2007 Jan; 132(1):166-75. PubMed ID: 17241869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells.
    Nakamura S; Ohtani H; Watanabe Y; Fukushima K; Matsumoto T; Kitano A; Kobayashi K; Nagura H
    Lab Invest; 1993 Jul; 69(1):77-85. PubMed ID: 7687311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune mechanisms in chronic inflammatory bowel disease.
    Braegger CP; MacDonald TT
    Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector cells, molecules and mechanisms in host-protective immunity to parasites.
    Mitchell GF
    Immunology; 1979 Oct; 38(2):209-23. PubMed ID: 389780
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammatory bowel disease: immunologic concepts.
    Schreiber S
    Hepatogastroenterology; 2000; 47(31):15-28. PubMed ID: 10690582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.